Trajectories and Experiences of People With Multimorbidity in Spain (LOXO-MULTIPAP) Project: a Mixed Methods Study
NCT ID: NCT06478745
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
3239950 participants
OBSERVATIONAL
2024-06-30
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Multimorbidity trajectories can help identify homogeneous groups of individuals with similar needs and prognoses, and help practitioners and health systems to personalize clinical interventions and preventive strategies. Capturing this dynamism is the only way to better understand the natural history of multimorbidity and shed light on hitherto unexplained findings.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Promotion Community-based Intervention Among Elderly People Through Self-managed MAHA Mobile App.
NCT05614479
SENior PRIorat: Participatory Research for the Improvement of Lifestyles, Quality of Life, Emotional Well-being, and Locomotor Abilities of Older Adults in the Priorat
NCT07189533
Technologies for Participatory Medicine and Health Promotion in the Elderly Population
NCT03504813
Self-management, Health Literacy and Social Capital in Socioeconomically Disadvantaged Older Adults
NCT02733523
The Reported Frequency of FP Visits and Family Difficulties Should Alert FPs and Help Them to Prevent Severe Outcomes in Multimorbid Outpatients
NCT03116061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Quantitative study: retrospective and prospective observational study. It integrates demographic and clinical information from electronic medical records and clinical-administrative databases. It involves the harmonisation of the cohorts of users of the public health system of the 7 participating regions.
* Qualitative study with a phenomenological and ethnographic approach using focus group techniques, semi-structured interviews and Photovoice to find out the perspective of patients and professionals in shared decision-making.
* Systematic literature review on the effectiveness of interventions on training, multimorbidity and polypharmacy in health professionals.
* Analysis:
* Quantitative study: Cluster, network and trajectory analysis
* Qualitative study: Thematic content analysis that will be triangulated among the members of the research team. Meanings will be interpreted and an explanatory framework will be created with the contributions of each type of informant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quantitative Aim
Ambispective longitudinal observational study
Retrospective and prospective cohort
* Retrospective study: Population-based retrospective cohort study with RWD. Patients ≥60 years old with 2 or more chronic diseases diagnosed before 01/01/2012, users of the public health system of the participating Autonomous Communities, will be included. Those who have had no contact with primary care defined as contact in a medical or nursing consultation in the previous two years (2010-2012) will be excluded.
* Prospective longitudinal observational open cohort study developed in the context of the MULTIPAP and LOXO studies.Patients over 65 years of age with multimorbidity (3 or more chronic pathologies) and polypharmacy (5 or more drugs taken during at least the last 3 months before inclusion in the study) under follow-up from primary care in Madrid, Aragon and Andalusia.
Qualitative Aim
Focus group, semi-structured interviews and Photovoice
Focus group, semi-structured interviews and Photovoice
The participants will be people with multimorbidity over 60 years of age recruited from Primary Care centers in Spain. A theoretical sampling will be carried out. Data will be collected through video and audio recordings from a total of 16 focus groups and 20 interviews in 7 regions, and will finally be transcribed for a triangulated thematic analysis. Two groups will be carried out with participation-action research methodology - Photovoice.
Systematic Review Aim
Systematic literature review on the effectiveness of interventions on training, multimorbidity and polypharmacy in health professionals.
Systematic review
No patient recruitment required
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retrospective and prospective cohort
* Retrospective study: Population-based retrospective cohort study with RWD. Patients ≥60 years old with 2 or more chronic diseases diagnosed before 01/01/2012, users of the public health system of the participating Autonomous Communities, will be included. Those who have had no contact with primary care defined as contact in a medical or nursing consultation in the previous two years (2010-2012) will be excluded.
* Prospective longitudinal observational open cohort study developed in the context of the MULTIPAP and LOXO studies.Patients over 65 years of age with multimorbidity (3 or more chronic pathologies) and polypharmacy (5 or more drugs taken during at least the last 3 months before inclusion in the study) under follow-up from primary care in Madrid, Aragon and Andalusia.
Focus group, semi-structured interviews and Photovoice
The participants will be people with multimorbidity over 60 years of age recruited from Primary Care centers in Spain. A theoretical sampling will be carried out. Data will be collected through video and audio recordings from a total of 16 focus groups and 20 interviews in 7 regions, and will finally be transcribed for a triangulated thematic analysis. Two groups will be carried out with participation-action research methodology - Photovoice.
Systematic review
No patient recruitment required
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 or more chronic diseases
Exclusion Criteria
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PI. Bernardino Oliva. Instituto Investigación Sanitaria Illes Balears
UNKNOWN
PI. Concepción Violan. Fundacion Jordi Gol i Gurina
UNKNOWN
PI Antonio Gimeno. Instituto de Investigación Sanitaria Aragón.
UNKNOWN
PI. Rafael Rotaeche. Instituto Investigación Bioguipuzcoa. Osakidetza
UNKNOWN
PI. Francisca Leiva. Instituto de Investigacion Biomedica de Malaga.
UNKNOWN
CI. Julian Librero. Navarra Biomed. Servicio Navarro de Salud
UNKNOWN
Fundación Investigacion en Innovacion Biomédica en Atención Primaria FIIBAP
UNKNOWN
Instituto de Investigación Sanitaria Gregorio Marañón
OTHER
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
OTHER
Gerencia de Atención Primaria, Madrid
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Isabel Del Cura-Gonzalez
Principal - Coordinator researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabel del Cura González, PhD,MD
Role: STUDY_DIRECTOR
Gerencia Asistencial de Atención Primaria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isabel del Cura González
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI22/00768 Isabel del Cura
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PI22/01651 Francisca Leiva
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PI22/00701 Antonio Gimeno
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PI22/01684 Bernardino Oliva
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PI22/01398 Concepción Violan
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PI22/01665 Rafael Rotaeche
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
20230033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.